Horizon Pharma: Phase 3 Trial Did Not Meet Primary, Secondary Endpoints

Results "not what we hoped," says CEO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.